Axim Biotechnologies Inc (OTCMKTS:AXIM) has announced that it’s CTO, Lekhram Changoer, recently delivered a keynote presentation, at the ExcipientFest 2017, held on April 25-26, 2017.The event...
Axim Biotechnologies Inc (OTCMKTS:AXIM) has announced that a member of its advisory board, Dr. Ilya Reznik, presented at the CannMed 2017 Conference, held at Harvard Medical...
Axim Biotechnologies Inc (OTCMKTS:AXIM) recently attended the Future Leaders in Biotech Industry Conference, held over the weekend, on April 7, 2017, in New York City. The...
Axim Biotechnologies Inc (OTCMKTS:AXIM) has announced that it would be attending the Future Leaders in the Biotech Industry Conference, on April 7, 2017, in New York....
Medical Marijuana Inc (OTCMKTS:MJNA) has announced that its major investment, Axim Biotechnologies Inc (OTCMKTS:AXIM), has signed a term-sheet agreement, with an Active Pharmaceutical Ingredient production company,...
Medical Marijuana Inc (OTCMKTS:MJNA) has announced that its major investment company, Axim Bio-technologies Inc (OTCMKTS:AXIM), is making progress with its phase-2 clinical trials, for the treatment...
As the race for patent filing in marijuana space becomes more volatile, Axim Biotechnologies Inc (OTCMKTS:AXIM), recently announced securing new patent grant for its cannabinoids based chewing...
Axim Biotechnologies Inc (OTCMKTS:AXIM) starts off 2017 with its efforts to develop a wider Cannabinoid Therapeutics portfolio, but with much lower cost. In a recent publication...